BIIB

BIIB

USD

Biogen Inc. Common Stock

$154.872-0.828 (-0.532%)

即時價格

Healthcare
Drug Manufacturers - General
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$155.700

最高

$156.220

最低

$154.010

交易量

1.72M

公司基本面

市值

22.7B

行業

Drug Manufacturers - General

國家

United States

交易統計

平均交易量

1.64M

交易所

NMS

貨幣

USD

52週範圍

最低 $110.04當前 $154.872最高 $175.86

相關新聞

Analyst Upgrades

Bernstein Maintains Market Perform on Biogen, Raises Price Target to $157

Bernstein analyst William Pickering maintains Biogen with a Market Perform and raises the price target from $155 to $157.

查看更多
Bernstein Maintains Market Perform on Biogen, Raises Price Target to $157
GlobeNewswire

Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025

Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights into the mechanism of action of felzartamab and advancing the understanding of its disease

查看更多
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
Analyst Upgrades

RBC Capital Maintains Outperform on Biogen, Lowers Price Target to $210

RBC Capital analyst Brian Abrahams maintains Biogen with a Outperform and lowers the price target from $217 to $210.

查看更多
RBC Capital Maintains Outperform on Biogen, Lowers Price Target to $210
Reuters

Biogen tops quarterly profit estimates, eyes deals to build early-stage pipeline

Biogen beat Wall Street estimates for third-quarter profit, helped by better-than-expected sales of some of its multiple sclerosis treatments.

查看更多
Biogen tops quarterly profit estimates, eyes deals to build early-stage pipeline